European Green Transition Plc EGT
LSE · Birleşik Krallık · Kamu Hizmetleri
GBp 11,75+0,25 (+%2,17)
Piyasa açık· · GBp · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa açık· · GBp · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
European Green Transition PLC (AIM:EGT) CFO Jack Kelly spoke with Proactive's Stephen Gunnion about the renewal of a five-year operations and maintenance contract covering 94 wind turbines with Drax Group, and what the agreement means for the company's wind services business and wider growth strategy. Kelly described the renewal as "great news," highlighting the importance of extending the relationship with a long-term customer for a further five years, providing revenue and financial visibility across a large proportion of the company's turbines through to 2031. The contract covers a technica
Pan African Resources PLC (LSE:PAF, OTCQX:PAFRY, JSE:PAN) has reported a record year, with gold production up almost 40%. Earnings nearly tripled, and it's proposing a record final dividend. European Green Transition PLC (AIM:EGT) says its first half was a "transformational period" after completing its Wind Services acquisition. Its repowering orderbook now represents a potential £126 million opportunity. HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has spudded the Ollie #1 at its Rudyard helium field in Montana. It's targeting the same formations that have already produced commercial-grade he
Ilika (AIM:IKA) says it's now a revenue-generating business, with initial royalties from its Stereax miniature solid-state batteries expected in its 2027 financial year. Releasing its 2026 results, the company said its larger Goliath battery is also attracting interest from defence and e-bike markets, including a collaboration with Brompton Bicycle. Allergy Therapeutics (AIM:AGY) says revenue growth accelerated in its second half, with full-year revenue up 9% to £59.9 million. Double-digit growth is expected next year as Grassmuno enters its first full peak treatment season. Ecora Royalties (L
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.